These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28480542)

  • 1. The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
    Nygård LH; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
    Prostate; 2017 Jun; 77(9):1029-1035. PubMed ID: 28480542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort.
    Kukko V; Kaipia A; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):373-378. PubMed ID: 29273728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia.
    Nygård LH; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
    Prostate; 2023 Feb; 83(3):246-258. PubMed ID: 36325820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Schenk JM; Calip GS; Tangen CM; Goodman P; Parsons JK; Thompson IM; Kristal AR
    Am J Epidemiol; 2012 Jul; 176(2):156-63. PubMed ID: 22759721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
    Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
    PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.
    St Sauver JL; Jacobson DJ; McGree ME; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Oct; 164(8):760-8. PubMed ID: 16905643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
    Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
    Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
    Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
    Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthyroidism is not a significant risk of benign prostatic hyperplasia: A nationwide population-based study.
    Man KM; Chen KB; Chen HY; Chiang JH; Su YC; Man SS; Xie DD; Wang Y; Zhang ZQ; Bi LK; Zhang T; Yu DX; Chen WC
    Medicine (Baltimore); 2018 Sep; 97(39):e12459. PubMed ID: 30278528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.
    Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
    Br J Cancer; 2014 Sep; 111(7):1421-31. PubMed ID: 25010865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
    Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
    Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.
    Murtola TJ; Vettenranta AM; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2018 Dec; 4(6):851-857. PubMed ID: 28753870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study.
    Peng YH; Huang CW; Liao WC; Chen HJ; Yin MC; Huang YM; Wu TN; Ho WC
    BMJ Open; 2017 Jun; 7(6):e015581. PubMed ID: 28645971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?
    Cindolo L; Pirozzi L; Sountoulides P; Fanizza C; Romero M; Castellan P; Antonelli A; Simeone C; Tubaro A; de Nunzio C; Schips L
    BMC Urol; 2015 Sep; 15():96. PubMed ID: 26391357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer Disease: A Matched Cohort Study.
    Orsel K; Taipale H; Raatikainen S; Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
    J Clin Psychopharmacol; 2018 Oct; 38(5):494-497. PubMed ID: 30102630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.